Apremilast for lithium-associated psoriasis

Apremilast for lithium-associated psoriasis

Bibliographic Details
Main Authors:	Joohyung Youh, Hajime Miyazawa, Hiroaki Iwata, Ken Natsuga, Hideyuki Ujiie
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-01-01
Series:	Dermatologica Sinica
Online Access:	http://www.dermsinica.org/article.asp?issn=1027-8117;year=2022;volume=40;issue=3;spage=186;epage=187;aulast=Youh

Similar Items

Erythrodermic psoriasis treated with apremilast
by: John Arcilla, et al.
Published: (2016-09-01)

Case report: Difference in outcomes between two cases of Hailey-Hailey disease treated with apremilast
by: Misako Yamaga, et al.
Published: (2022-09-01)

Recurrence of Melanoma after Starting Apremilast for Psoriasis
by: Thomas G. Salopek
Published: (2017-08-01)

Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid Models
by: Hideyuki Ujiie, et al.
Published: (2019-06-01)

Recurrent generalized pustular psoriasis possibly triggered by apremilast
by: Wen-Ming Wang, et al.
Published: (2020-05-01)

Systemic Retinoids for Generalized Verrucosis Due to Congenital Immunodeficiency: Case Reports and Review of the Literature
by: Hideyuki Kosumi, et al.
Published: (2023-03-01)

Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis
by: Dmitry A. Verbenko, et al.
Published: (2020-12-01)

Apremilast in psoriasis and beyond: Big hopes on a small molecule
by: T P Afra, et al.
Published: (2019-01-01)

Cost-effectiveness of apremilast in moderate to severe psoriasis in the United Kingdom
by: Anthony Bewley, et al.
Published: (2018-01-01)

Dramatic response of cutaneous, nail, and joint symptoms of psoriasis to apremilast
by: Meghana Bathina, et al.
Published: (2019-01-01)

The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios
by: Rajagopalan M, et al.
Published: (2021-08-01)

Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
by: Forchhammer S, et al.
Published: (2015-09-01)

Apremilast: target synthetic drug for the treatment of psoriatic arthritis and psoriasis
by: Yu. L. Korsakova, et al.
Published: (2018-07-01)

Early Discontinuation of Apremilast in Patients with Psoriasis and Gastrointestinal Comorbidities: Rates and Associated Risk Factors
by: Lana Schmidt, et al.
Published: (2023-07-01)

New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast.
by: Palfreeman, A, et al.
Published: (2013)

Efficacy of apremilast for psoriasis: a meta-analysis of randomized controlled studies
by: Yashu Liu, et al.
Published: (2022-09-01)

Psoriasis In Patients With Active Lung Cancer: Is Apremilast a Safe Option?
by: Zoe Apalla, et al.
Published: (2019-10-01)

Apremilast for immune checkpoint inhibitor-induced psoriasis: A case series
by: Ander Mayor Ibarguren, MD, et al.
Published: (2021-05-01)

New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast
by: Palfreeman AC, et al.
Published: (2013-03-01)

THE EFFICACY AND SAFETY OF THE NEW DRUG APREMILAST FOR THE TREATMENT OF PSORIASIS AND PSORIATIC ARTHRITIS
by: Yu. L. Korsakova, et al.
Published: (2016-12-01)

Apremilast
by: Nihal Kundakçı
Published: (2022-04-01)

<i>PDE4</i> Gene Family Variants Are Associated with Response to Apremilast Treatment in Psoriasis
by: Kalliopi Liadaki, et al.
Published: (2024-03-01)

Efficacy of Apremilast Gels in Mouse Model of Imiquimod-Induced Psoriasis Skin Inflammation
by: Marcelle Silva-Abreu, et al.
Published: (2023-09-01)

Real-world data on the efficacy and safety of apremilast in Japanese patients with plaque psoriasis
by: Chika Ohata, et al.
Published: (2019-05-01)

Real-world efficacy and safety of apremilast monotherapy in the management of moderate-to-severe Psoriasis
by: Bela J Shah, et al.
Published: (2020-01-01)

Generalized pustular psoriasis treated with apremilast in a patient with multiple medical comorbidities
by: Caleb Jeon, BS, et al.
Published: (2017-11-01)

Successful Treatment of Refractory Palmoplantar Pustular Psoriasis With Apremilast: A Case Series
by: Sascha Ständer, et al.
Published: (2020-10-01)

Real-world insight on apremilast therapy in patients with plaque psoriasis: Indian experience
by: Abhishek De, et al.
Published: (2020-01-01)

Dermatological management in special population affected by psoriasis: A case report of an amputated transgender with psoriasis treated with apremilast
by: Letizia Silocchi, et al.
Published: (2023-01-01)

Apremilast Improves Endothelial Glycocalyx Integrity, Vascular and Left Ventricular Myocardial Function in Psoriasis
by: Ignatios Ikonomidis, et al.
Published: (2022-01-01)

Pediatric scalp psoriasis: Therapeutic response to oral apremilast: A report of two cases
by: Anil Kumar Panda, et al.
Published: (2022-01-01)

Commentary: Successful treatment of refractory palmoplantar pustular psoriasis with apremilast: a case series
by: Madison Hackley, et al.
Published: (2023-10-01)

Experience in the treatment of psoriasis patients using Apremilast, a selective signalling pathway inhibitor
by: N. V. Kungurov, et al.
Published: (2019-04-01)

Apremilast in psoriasis patients with serious comorbidities: a case series and systematic review of literature
by: Aikaterini Tsentemeidou, et al.
Published: (2022-10-01)

Colocalization of psoriasis and vitiligo treated with apremilast and narrowband ultraviolet B combination in an adolescent girl
by: Trashita Hassanandani, et al.
Published: (2020-01-01)

[Translated article] Effectiveness and Drug Survival of Apremilast in 65 Patients With Psoriasis and/or Psoriatic Arthritis
by: P. Garbayo Salmons, et al.
Published: (2022-05-01)

Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report
by: Maria Anna Siciliano, et al.
Published: (2020-10-01)

Switch Rates and Total Cost of Care Associated with Apremilast and Biologic Therapies in Biologic-Naive Patients with Plaque Psoriasis
by: Kaplan DL, et al.
Published: (2020-07-01)

Treating moderate plaque psoriasis: prospective 6-month chart review of patients treated with apremilast
by: Melissa L. F. Knuckles, et al.
Published: (2019-07-01)

Characteristics and outcomes of patients with psoriasis treated with apremilast in the real-world in Austria – results the APPRECIATE study
by: Constanze Jonak, et al.
Published: (2023-02-01)